Pharma Journalist -

AbbVie announced that the European Commission (EC) has approved the type-II variation application for VENCLYXTO (venetoclax) in combination with rituximab for the treatment of patients…
Read More...

SMi Reports: Registration is now officially open for SMi’s Superbugs & Superdrugs Conference, returning for its 21st year to London, UK on the 18th and 19th March 2019.  As the…
Read More...

Puration confirmed the developing joint venture agreement with Kali, Inc. and Nouveau Life Pharmaceuticals, Inc. to develop cannabis pharmaceutical products. Puration further confirms…
Read More...

As part of CoreRx, Inc's growth in expanding its cGMP manufacturing capabilities to support niche commercial products, we are pleased to announce the completed installation of the Optel…
Read More...

Avance Biosciences announced that its Houston facility was inspected by the U.S. Food and Drug Administration on October 01 through October 04, 2018.  This inspection focused on the…
Read More...

Genesis Biotechnology Group (GBG) and its CRO arm Genesis Drug Discovery & Development (GD3) announced today that it has entered into a partnership with Yale University to offer an…
Read More...

Distributed Bio announced a discovery collaboration with H3 Biomedicine, Inc. designed to help accelerate the discovery of novel cancer therapeutics. The collaboration will leverage…
Read More...

Novartis announced that it has entered into a clinical development agreement with Pfizer which will include a study combining tropifexor and one or more Pfizer compounds for the…
Read More...

AstraZeneca has agreed to divest the prescription medicine rights to Nexium (esomeprazole) in Europe, as well as the global rights (excluding the US and Japan) to Vimovo …
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has approved INVOKANA (canagliflozin) to reduce the risk of…
Read More...